STAT5A and breast cancer: SOCS3 has a potent inhibitory effect on STAT5, and its expression is STAT5 dependent in breast cancer cells [9], and appears to be independent from STAT5 activation in vivo [10] and not a prominent negative regulator of STAT5 signaling in mouse during pregnancy and lactation [11].